Mainolfi Nello

Company

Date

Role

Action

Shares

Amount

Of holding

KYMR Kymera Therapeutics, Inc.

1 Oct 2026

Chief Executive Officer

Sold on a plan

30,000

$3.41M

4.3%

KYMR Kymera Therapeutics, Inc.

7 Jul 2026

Chief Executive Officer

Sold on a plan

50,000

$5.95M

7.0%

KYMR Kymera Therapeutics, Inc.

1 Jul 2026

Chief Executive Officer

Sold on a plan

80,000

$9.22M

10.7%

KYMR Kymera Therapeutics, Inc.

29 Apr 2026

Chief Executive Officer

Sold on a plan

30,000

$2.44M

4.3%

KYMR Kymera Therapeutics, Inc.

25 Feb 2026

Chief Executive Officer

Sold on a plan

30,000

$2.71M

4.3%

KYMR Kymera Therapeutics, Inc.

31 Dec 2025

Chief Executive Officer

Sold on a plan

30,000

$2.34M

4.3%

KYMR Kymera Therapeutics, Inc.

8 Dec 2025

Chief Executive Officer

Sold on a plan

100,000

$8.92M

13.1%

KYMR Kymera Therapeutics, Inc.

29 Oct 2025

Chief Executive Officer

Sold on a plan

30,000

$1.83M

4.3%

KYMR Kymera Therapeutics, Inc.

16 Sep 2025

Chief Executive Officer

Sold on a plan

30,000

$1.47M

4.3%

KYMR Kymera Therapeutics, Inc.

3 Jun 2025

Chief Executive Officer

Sold on a plan

30,000

$1.47M

4.3%

KYMR Kymera Therapeutics, Inc.

12 Jan 2022

Chief Executive Officer

Sold, plan not stated

8,612

$448.55K

1.8%

KYMR Kymera Therapeutics, Inc.

11 Jan 2022

Chief Executive Officer

Sold, plan not stated

16,923

$913.79K

3.5%

KYMR Kymera Therapeutics, Inc.

10 Jan 2022

Chief Executive Officer

Sold, plan not stated

22,465

$1.20M

4.5%

KYMR Kymera Therapeutics, Inc.

11 Oct 2021

Chief Executive Officer

Sold, plan not stated

6,456

$346.59K

1.4%

KYMR Kymera Therapeutics, Inc.

8 Oct 2021

Chief Executive Officer

Sold, plan not stated

41,544

$2.36M

8.2%

KYMR Kymera Therapeutics, Inc.

4 Aug 2021

Chief Executive Officer

Sold, plan not stated

1,037

$62.25K

0.2%

KYMR Kymera Therapeutics, Inc.

3 Aug 2021

Chief Executive Officer

Sold, plan not stated

5,669

$340.53K

1.2%

KYMR Kymera Therapeutics, Inc.

2 Aug 2021

Chief Executive Officer

Sold, plan not stated

23,456

$1.41M

4.9%

KYMR Kymera Therapeutics, Inc.

30 Jul 2021

Chief Executive Officer

Sold, plan not stated

6,279

$377.17K

1.4%

KYMR Kymera Therapeutics, Inc.

29 Jul 2021

Chief Executive Officer

Sold, plan not stated

680

$40.80K

0.2%

KYMR Kymera Therapeutics, Inc.

28 Jul 2021

Chief Executive Officer

Sold, plan not stated

3,864

$232.41K

0.8%

KYMR Kymera Therapeutics, Inc.

26 Jul 2021

Chief Executive Officer

Sold, plan not stated

9,015

$542.24K

2.0%

KYMR Kymera Therapeutics, Inc.

8 Jul 2021

Chief Executive Officer

Sold, plan not stated

48,000

$2.39M

9.6%

KYMR Kymera Therapeutics, Inc.

10 Jun 2021

Chief Executive Officer

Sold, plan not stated

23,009

$1.18M

5.3%

KYMR Kymera Therapeutics, Inc.

9 Jun 2021

Chief Executive Officer

Sold, plan not stated

5,752

$287.72K

1.4%

KYMR Kymera Therapeutics, Inc.

8 Jun 2021

Chief Executive Officer

Sold, plan not stated

270

$13.50K

0.1%

KYMR Kymera Therapeutics, Inc.

7 Jun 2021

Chief Executive Officer

Sold, plan not stated

12,724

$638.04K

3.0%

KYMR Kymera Therapeutics, Inc.

12 May 2021

Chief Executive Officer

Sold, plan not stated

8,245

$412.68K

2.0%

KYMR Kymera Therapeutics, Inc.

26 Apr 2021

Chief Executive Officer

Sold, plan not stated

2,768

$111.23K

0.7%

KYMR Kymera Therapeutics, Inc.

23 Apr 2021

Chief Executive Officer

Sold, plan not stated

680

$27.21K

0.2%

KYMR Kymera Therapeutics, Inc.

22 Apr 2021

Chief Executive Officer

Sold, plan not stated

10,959

$441.18K

2.7%

KYMR Kymera Therapeutics, Inc.

19 Apr 2021

Chief Executive Officer

Sold, plan not stated

653

$26.12K

0.2%

KYMR Kymera Therapeutics, Inc.

15 Apr 2021

Chief Executive Officer

Sold, plan not stated

4,940

$199.04K

1.2%

KYMR Kymera Therapeutics, Inc.

12 Apr 2021

Chief Executive Officer

Sold, plan not stated

15,267

$497.98K

3.9%

KYMR Kymera Therapeutics, Inc.

9 Apr 2021

Chief Executive Officer

Sold, plan not stated

22,794

$767.75K

5.7%

KYMR Kymera Therapeutics, Inc.

8 Apr 2021

Chief Executive Officer

Sold, plan not stated

9,939

$347.83K

2.6%